Alimentary Pharmacology Flashcards

1
Q

drugs for acid suppression

A

antacids

H2 Receptor antagonists

PPI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

drugs affecting GI motility

A

anti-emetics

antimuscarinics/ other anti-spasmodics

antimotility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

drugs for inflammatory bowel disease

A

aminosalicylates

corticosteroids

immunosuppressants

biologics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

drugs affecting intestinal secretions

A

bile acid sequestrates

ursodeoxycholic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe antacids (e.g. Maalox)

A

contains Mg or Aluminium

neutralises gastric acid

taken when symptoms occure

not preventative or curative, purely symptomatic treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe alginates (e.g. gaviscon)

A

form a viscous gel that floats on stomach contents and reduces reflux

acid suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe H2 receptor antagonists mechanism and use (e.g. ranitidine)

A

blocks histamine receptor therefore reducing acid secretion

indicated in GORD/ peptic ulcer disease

given orally or IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe PPI mechanism and use (e.g. omeprazole)

A

irreversibly block proton pump and therefore reduce acid secretion

indicated in GORD/ peptic ulcer disease

oral or IV administration

widely used (over used?)

triple therapy if associated with H Pylori

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

problems associated with PPI

A

-GI upset

predisposition to:

  • C.Diff
  • Hypomagnesaemia
  • B12 Deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

function of pro kinetic agents on the gut

A

increase gut motility and gastric emptying

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe the mechanism of action of GI motility drugs

A

not clear

involves parasympathetic nervous systems control of smooth muscle and sphincter tone (via ACh)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

examples of drugs that decrease GI motility

A

loperamide (ammonium)

opiods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

mechanism of action of drugs that decrease GI motility

A

via opiate receptors in GI tract to decrease ACh release.
decrease in smooth muscle contraction
increase anal sphincter tone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

explain caution associated with GI motility reduction

A

don’t want to use it cause want to get rid of the organism causing it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

use of anti-spasmodics

A

reduce symptoms associated with IBS, renal colic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

mechanisms of action of anti-spasmodics

A
  • anti-cholinergic muscarininc antagonists
  • direct smooth muscle relaxants
  • calcium channel blockers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how do anti-cholinergic muscarinic antagonists work

A

inhibit smooth muscle constriction in the gut wall, producing muscle relaxation and reduction spasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how do calcium channel blockers work as anti-spasmodics

A

reduce calcium required for smooth muscle contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

4 types of laxatives

A

bulk

osmotic

stimulant

softeners

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

how do laxatives work

A

work by increasing bulk or drawing fluid into gut

21
Q

issues with laxatives

A

obstruction

route administration

need for other measures (e.g. osmotic laxatives will not work without adequate fluid intake)

Misuse

22
Q

mechanism of action of aminosalicylayes

A

unclear but but anti-inflammatory

23
Q

use of aminosalicylayes

A

IBD

oral or rectal administration

24
Q

adverse effects aminosalicylayes

A

GI upset

blood dycrasias

renal impairment

25
Corticosteroids
anti-inflammatory effects given orally or rectally
26
concerns and contraindications of Corticosteroids
osteoperosis cushingoid features including weight gain Increased susceptibility to infection addisonian crisis with abrupt withdrawal
27
use and mechanism of action of immunosuppresents
IBD prevents the formation of purines required for DNA synthesis so reduces immune cell proliferation
28
adverse effects of immunosuppressents
bone marrow suppression azathioprine hypersensitivity organ damage (lung, liver, pancreas) numerous DD interactions
29
how do biologics work when treating IBD
addresses inflammatory response but not underlying disease process so course of disease after discontinuation is unclear
30
what is the primary biologic used for treating IBD
anti-TNFa antibodies
31
anti-TNFa antibodies e.g. infliximab
primary biologic used for treating IBD
32
Cautions/ contraindications of infliximab
current TB or other serious infection multiple sclerosis pregnancy/ breast feeding
33
infliximab
type of anti-TNFa antibody prevents action of TNFa
34
adverse effects of infliximab
risk of infection (particularly TB) infusion reaction (e.g. fever, itch) anaemia thrombocytopenia neutropenia malignancy
35
cholestyramine function
reduces bile salt by binding them in the gut and then excreting them as an insoluble complex
36
possible effects of cholestyramine
- absorption of other drugs may be effected | - fat soluble vitamin absorption might be effected, so may decrease vitamin K levels
37
purpose of Ursodeoxycholic Acid
used to treat gallstones and primary biliary cirrhosis
38
mechanism of action Ursodeoxycholic Acid
inhibits an enzyme involved in the formation of cholesterol, altering amount in bile and slowly dissolving non-calcified stones
39
what is absorption dependant on
pH gut length transit time
40
what happens to gut function when theres low albumin
decreased binding and increased free drug concentration
41
features of metabolism that can be effected by ADME drugs
liver enzymes gut bacteria gut wall infection liver blood flow
42
what percentage of hospital admissions are due to ADRs
6.5%
43
what percentage of hospital admissions are killed due to ADRs
0.1-0.2%
44
effects of changes to gut bacteria
loss oF OCP activity reduced vit K absorption overgrowth of pathogenic bacteria
45
GI adverse effects of drug induced liver injury
intrinsic hepatotoxicity idiosyncratic hepatotoxicity
46
risk factors for ADRs
age (elderly) female high alcohol consumption genetic factors malnourishment
47
caution to be considered when prescribing warfarin to a patient with liver disease
clotting factors are already low
48
caution to be considered when prescribing aspirin/NSAIDs to a patient with liver disease
can increase bleeding time, in combination with a deficiency in clotting factors NSAIDs can worsen ascites due to fluid retention
49
caution to be considered when prescribing opiates/benzodiazepines to a patient with liver disease
may precipitate encephalopathy by increasing sedation